“…[6] Thelimited output for these challenging molecules might find its origins in the difficulty to prepare these frameworks,w hich has hampered any real study on their potential bioactive properties.T herefore,w eb elieved that designing ag eneral approach to access these synthons could make ad ifference,n ot only by boosting the interest in them from the pharmaceutical industry but also,more generally,by filling avoid in the synthesis of N-heterocycles.T oaccomplish this objective,w ew ondered whether the aza-Piancatelli cyclization could be exploited to close this gap. [7] Over the past few years,t his Nazarov-type electrocyclization [8] has been at the heart of our research program, granting rapid access to privileged building blocks such as 4-aminocyclopentenones,c yclopenta [b]pyrroles,a nd cyclopenta- [b]piperazinones from readily available 2-furylcarbinols. [9] In that respect, by taking ac lose look at the compounds generated during the cyclization, we reasoned that the introduction of an itrogen functionality on the carbinol moiety might be the answer to this issue.I np ractice,o nce the aza-Piancatelli cyclization is complete (first step), adding ab ase to the reaction mixture would be sufficient to trigger aM ichael addition (second step) and assemble tetrahydrobenzo [b]azepines in ao ne-pot sequence.…”